Question 1

What is ADC Therapeutics?

Accepted Answer

ADC Therapeutics is a Company.

Question 2

How often does ADC Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was ADC Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 11, 2026.

Question 4

When was ADC Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 28, 2026.

Question 5

What is ADC Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: -80 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is ADC Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving ADC Therapeutics?

Accepted Answer

ADC Therapeutics faces fraud investigation (Jun 11, 2026, 6 articles).

Question 8

How did the "ADC Therapeutics faces fraud investigation" event impact ADC Therapeutics?

Accepted Answer

ADC Therapeutics is facing a securities fraud investigation by Pomerantz LLP after its stock price plummeted due to disappointing Phase 3 trial results for Loncastuximab tesirine.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.